Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1996-05-28
1998-02-17
Feisee, Lila
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
43524027, 5303879, 436512, A61K 39395
Patent
active
057190321
ABSTRACT:
Methods and compositions are provided for detecting antigens having a specific epitope associated with melanoma and prostatic carcinoma. The epitope is present in melanoma cells and prostatic cancer cells but is essentially absent from melanocytes and normal prostatic tissue. The antibody can be used in diagnostic methods for histochemical detection of human melanoma and prostate carcinoma, of various progression stages and in treatment of melanoma and prostate carcinoma.
REFERENCES:
patent: 4590071 (1986-05-01), Scannon et al.
Gown, et al., The American J. Pathology (1986) 123:195-203.
Sevier et al. Clinal Chemistry 27/11: 1797-1806, 1981.
Wittbrodt et al. Nature 341:415-421 1989.
Parker et al. Biochemistry 25, 5425-5432, 1986.
Lerner, T. Nature, 299: 592-596, 1982.
Staerz, et al. PNAS. 83: 1453, 1986.
Waldman, W. Science, 252: 1657-1662, 1991.
Real et al. Cancer Res. 46: 4726-4731, 1986.
Carrasquillo et al. Cancer Treatment Reports 68: 317, 1984.
Hird, et al. Genes & Cancer, pp. 183-189 1990.
Davis Minh-Tam B.
Feisee Lila
University of British Columbia
LandOfFree
Melanoma and prostate cancer specific antibodies for immunodetec does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Melanoma and prostate cancer specific antibodies for immunodetec, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanoma and prostate cancer specific antibodies for immunodetec will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1783322